| Net Cash Provided by (Used in) Operating Activities |
$19,030 |
USD |
16% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$5,000 |
USD |
-119% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
394,500,000 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
11,396,638 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$24,030 |
USD |
-685% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$7,512 |
USD |
-43% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$680 |
USD |
70% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$545,513 |
USD |
181% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$545,513 |
USD |
181% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$12 |
USD |
0% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$29,981 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$1,726,921 |
USD |
4.8% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$6,296 |
USD |
63% |
Q1 2025 |
Q1 2025 |